Malleable multi-component implants and materials therefor

Patent metadata

Field	Value
Publication number	US-9730982-B2
Application number	US-201414492957-A
Country	US
Kind code	B2
Filing date	Sep 22, 2014
Priority date	Mar 27, 2008
Publication date	Aug 15, 2017
Grant date	Aug 15, 2017

Abstract

Described are implantable, malleable medical materials comprising mineral particles, insoluble collagen fibers, and a gel-forming polysaccharide component and/or another added gel-former. The malleable medical materials can be used treat bone or other tissue defects in patients, including in conjunction with biologically active factors such as osteogenic proteins. Also described are methods and materials that can be used to prepare the malleable medical materials.

First claim

What is claimed is:

1. A method for preparing an implantable osteogenic medical material, comprising: providing a dried, porous material that includes a particulate mineral material embedded within a disruptable matrix, said matrix comprising insoluble collagen, soluble collagen and a polysaccharide component, the polysaccharide component including one or more polysaccharide compounds comprising dextran, the polysaccharide component at a level of about 0.01 g/cc to about 0.2 g/cc, and one or more ionic polysaccharide compounds; applying an aqueous medium to the dried, porous material and disrupting the matrix so as to prepare a malleable, cohesive, shape-retaining putty that comprises 40% to 75% by weight of water, and applying a cationic gelling agent to the one or more ionic polysaccharide compounds to form an anionically-cross-linked gel with one or more divalent or trivalent cations, wherein the aqueous medium comprises polyethylene glycol, and the particulate mineral material is embedded within the disruptable matrix at a level of about 0.25 g/cc to about 0.55 g/cc, and the insoluble collagen particles are at a level of about 0.04 g/cc to about 0.15 g/cc.

2. The method of claim 1 , wherein the aqueous medium includes a bone morphogenic protein dissolved therein at a level of about 0.6 mg/cc to about 2 mg/cc.

3. The method of claim 1 , wherein: the particulate mineral material constitutes about 70% to 90% by weight of the dried, porous material; the insoluble collagen constitutes about 1% to about 15% of the dried, porous material; and the polysaccharide component constitutes about 1% to about 15% of the dried, porous material.

4. The method of claim 1 , wherein the particulate mineral material comprises biphasic calcium phosphate having a weight ratio of tricalcium phosphate to hydroxyapatite of about 70:30 to about 95:5; and the insoluble collagen to soluble collagen are at a weight ratio of 75:25 to about 65:35.

Assignees

• Warsaw Orthopedic Inc
• Warsaw Orthopedic Inc

Inventors

• Mckay William F
• Scifert Jeffrey L
• Remsen Kathy
• Billy Didier
• Gillissen Mirian
• Vickers Scott M

Classifications

• A61K38/1875 Primary

  Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor · CPC title

• A61P19/00

  Drugs for skeletal disorders · CPC title

• A61L27/26

  Mixtures of macromolecular compounds · CPC title

• A61L2300/414

  Growth factors · CPC title

• A61L27/54

  Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title